PubMed

Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome.

Hutchison SK, Harrison C, Stepto N, Meyer C, Teede HJ.

Diabetes Care. 2008 Jul;31(7):1427-32. Epub 2008 Apr 4.PMID: 18390799 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome.

Meyer C, McGrath BP, Teede HJ.

Diabetes Care. 2007 Mar;30(3):471-8.PMID: 17327307 [PubMed - indexed for MEDLINE]Related articlesFree article

Low free plasma levels of retinol-binding protein 4 in insulin-resistant subjects with polycystic ovary syndrome.

Diamanti-Kandarakis E, Livadas S, Kandarakis SA, Papassotiriou I, Margeli A.

J Endocrinol Invest. 2008 Nov;31(11):950-5.PMID: 19169049 [PubMed - indexed for MEDLINE]Related articles

Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism.

Hahn S, Backhaus M, Broecker-Preuss M, Tan S, Dietz T, Kimmig R, Schmidt M, Mann K, Janssen OE.

Eur J Endocrinol. 2007 Aug;157(2):201-7.PMID: 17656599 [PubMed - indexed for MEDLINE]Related articlesFree article

Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study.

Morin-Papunen L, Vauhkonen I, Koivunen R, Ruokonen A, Martikainen H, Tapanainen JS.

J Clin Endocrinol Metab. 2003 Jan;88(1):148-56.PMID: 12519844 [PubMed - indexed for MEDLINE]Related articlesFree article

Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment.

Heutling D, Schulz H, Nickel I, Kleinstein J, Kaltwasser P, Westphal S, Mittermayer F, Wolzt M, Krzyzanowska K, Randeva H, Schernthaner G, Lehnert H.

J Clin Endocrinol Metab. 2008 Jan;93(1):82-90. Epub 2007 Nov 6.PMID: 17986642 [PubMed - indexed for MEDLINE]Related articlesFree article

Retinol-binding protein 4 is associated with insulin resistance, but appears unsuited for metabolic screening in women with polycystic ovary syndrome.

Möhlig M, Weickert MO, Ghadamgahi E, Arafat AM, Spranger J, Pfeiffer AF, Schöfl C.

Eur J Endocrinol. 2008 Apr;158(4):517-23.PMID: 18362299 [PubMed - indexed for MEDLINE]Related articlesFree article

Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study.

Morin-Papunen LC, Vauhkonen I, Koivunen RM, Ruokonen A, Martikainen HK, Tapanainen JS.

J Clin Endocrinol Metab. 2000 Sep;85(9):3161-8.PMID: 10999803 [PubMed - indexed for MEDLINE]Related articlesFree article

Elevated serum RBP4 is associated with insulin resistance in women with polycystic ovary syndrome.

Weiping L, Qingfeng C, Shikun M, Xiurong L, Hua Q, Xiaoshu B, Suhua Z, Qifu L.

Endocrine. 2006 Dec;30(3):283-7.PMID: 17526940 [PubMed - indexed for MEDLINE]Related articles

Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance.

Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, Keay SD, Kennedy CR, Lehnert H, Randeva HS.

Diabetes. 2008 Jun;57(6):1501-7. Epub 2008 Mar 28.PMID: 18375437 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.

Wu J, Zhu Y, Jiang Y, Cao Y.

Gynecol Endocrinol. 2008 Jul;24(7):392-8.PMID: 18608522 [PubMed - indexed for MEDLINE]Related articles

Serum levels of retinol-binding protein 4 and adiponectin in women with polycystic ovary syndrome: associations with visceral fat but no evidence for fat mass-independent effects on pathogenesis in this condition.

Barber TM, Hazell M, Christodoulides C, Golding SJ, Alvey C, Burling K, Vidal-Puig A, Groome NP, Wass JA, Franks S, McCarthy MI.

J Clin Endocrinol Metab. 2008 Jul;93(7):2859-65. Epub 2008 Apr 29.PMID: 18445670 [PubMed - indexed for MEDLINE]Related articlesFree article

Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids.

Tan BK, Chen J, Lehnert H, Kennedy R, Randeva HS.

J Clin Endocrinol Metab. 2007 Jul;92(7):2764-72. Epub 2007 Apr 24.PMID: 17456573 [PubMed - indexed for MEDLINE]Related articlesFree article

Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome.

Morin-Papunen L, Rautio K, Ruokonen A, Hedberg P, Puukka M, Tapanainen JS.

J Clin Endocrinol Metab. 2003 Oct;88(10):4649-54.PMID: 14557435 [PubMed - indexed for MEDLINE]Related articlesFree article

Retinol-binding protein 4 in polycystic ovary syndrome--association with steroid hormones and response to pioglitazone treatment.

Aigner E, Bachofner N, Klein K, De Geyter C, Hohla F, Patsch W, Datz C.

J Clin Endocrinol Metab. 2009 Apr;94(4):1229-35. Epub 2009 Jan 21.PMID: 19158194 [PubMed - indexed for MEDLINE]Related articles

Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome.

Luque-Ramírez M, Alvarez-Blasco F, Botella-Carretero JI, Martínez-Bermejo E, Lasunción MA, Escobar-Morreale HF.

J Clin Endocrinol Metab. 2007 Jul;92(7):2453-61. Epub 2007 Apr 10.PMID: 17426085 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM.

J Clin Endocrinol Metab. 2000 Aug;85(8):2767-74.PMID: 10946879 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study.

Elter K, Imir G, Durmusoglu F.

Hum Reprod. 2002 Jul;17(7):1729-37.PMID: 12093831 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.

Falsetti L, Pasinetti E.

Acta Obstet Gynecol Scand. 1995 Jan;74(1):56-60.PMID: 7856434 [PubMed - indexed for MEDLINE]Related articles

Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses.

Luque-Ramírez M, Alvarez-Blasco F, Botella-Carretero JI, Sanchón R, San Millán JL, Escobar-Morreale HF.

Diabetes Care. 2007 Sep;30(9):2309-13. Epub 2007 May 29.PMID: 17536071 [PubMed - indexed for MEDLINE]Related articlesFree article